Factors of chemoresistant pulmonary tuberculosis progression in patients receiving palliative treatment
Objective – to define factors of chemoresistant pulmonary tuberculosis (CRPTB) progression in patients receiving palliative treatment by means of their QL, TNF-α levels and body mass index complex assessment. Materials and methods. 81 CRPTB patients were examined and divided into two groups: th...
Main Authors: | O. M. Raznatovska, G. V. Khudiakov |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2018-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/130829/130849 |
Similar Items
-
Diagnostic value of cystatin C in patients with drug-resistant pulmonary tuberculosis receiving palliative care
by: O. M. Raznatovska, et al.
Published: (2019-04-01) -
The clinical significance of insulin-like growth factor-1 and cystatin C in predicting the risk of developing complications of chemoresistant pulmonary tuberculosis in patients undergoing palliative treatment
by: O. M. Raznatovska, et al.
Published: (2019-06-01) -
Assessment of palliative patients with chemoresistance pulmonary tuberculosis life quality in the conditions of specialized hospital at the corrective labour colony
by: O. M. Raznatovska, et al.
Published: (2017-06-01) -
Features of changes in insulin-like growth factor-1 in patients with chemoresistant pulmonary tuberculosis who are on palliative treatment
by: H. V. Khudiakov
Published: (2019-03-01) -
Comparative Evaluation of the Efficacy and Tolerability of Chemotherapy in Patients with Drug-Resistant Pulmonary Tuberculosis Using Terizidone and Cycloserine in the Comprehensive Treatment
by: O.M. Raznatovska, et al.
Published: (2015-11-01)